-Kenji Hashimoto Researcher Activity Profile

Research Author Detailed Information 

Kenji Hashimoto Publication Rate By Year

Kenji Hashimoto has published 27 paper(s) in 2007, 7 paper(s) in 2008, for a total of 34 research publications in total.

Kenji K Hashimoto Author Information

LAST NAME: hashimoto

FIRST NAME: kenji

INITIALS: K

AFFILIATION:

Papers

Kenji Hashimoto's Publication Record

1. Disruption of reelin signaling attenuates methamphetamine-induced hyperlocomotion. Year Published: 2007
Department of Anatomy and Neuroscience, Hamamatsu University School of Medicine, Hamamatsu, Japan.
2. Minocycline attenuates hyperlocomotion and prepulse inhibition deficits in mice after administration of the NMDA receptor antagonist dizocilpine. Year Published: 2007
Division of Clinical Neuroscience, Chiba University Center for Forensic Mental Health, 1-8-1 Inohana, Chiba 260-8670, Japan.
3. Gender-specific association of a functional coding polymorphism in the Neuropeptide S receptor gene with panic disorder but not with schizophrenia or attention-deficit/hyperactivity disorder. Year Published: 2007
Department of Pharmacology, University of California Irvine, 360 Med Surge 2, Irvine, CA 92697, USA.
4. [Development of new drugs targeting glial cells] Year Published: 2007
kudoy@ls.toyaku.ac.jp
5. High occupancy of sigma-1 receptors in the human brain after single oral administration of fluvoxamine: a positron emission tomography study using [11C]SA4503. Year Published: 2007
Division of Clinical Neuroscience, Chiba University Center for Forensic Mental Health, Chiba, Japan.
6. Fabp7 maps to a quantitative trait locus for a schizophrenia endophenotype. Year Published: 2007
Laboratory for Molecular Psychiatry, RIKEN Brain Science Institute, Saitama, Japan.
7. Decreased serum levels of platelet-endothelial adhesion molecule (PECAM-1) in subjects with high-functioning autism: a negative correlation with head circumference at birth. Year Published: 2007
Department of Psychiatry and Neurology, Hamamatsu University School of Medicine, Hamamatsu, Shizuoka, Japan. hashimoto@faculty.chiba-u.jp
8. Increased levels of glutamate in brains from patients with mood disorders. Year Published: 2007
Division of Clinical Neuroscience, Chiba University Center for Forensic Mental Health, Inohana, Chiba, Japan. hashimoto@faculty.chiba-u.jp
9. Intraventricular meningioma with anaplastic transformation and metastasis via the cerebrospinal fluid. Year Published: 2007
Department of Pathology, Osaka Red Cross Hospital, Osaka, Japan. masa-s@sings.jp
10. d-Serine and a glycine transporter inhibitor improve MK-801-induced cognitive deficits in a novel object recognition test in rats. Year Published: 2007
Discovery Pharmacology, Molecular Function and Pharmacology Laboratories, Taisho Pharmaceutical Co. Ltd., 1-403 Yoshino-cho, Kita-ku, Saitama 331-9530, Japan.
11. Gender-specific association of a functional coding polymorphism in the Neuropeptide S receptor gene with panic disorder but not with schizophrenia or attention-deficit/hyperactivity disorder. Year Published: 2007
Department of Pharmacology, University of California Irvine, 360 Med Surge 2, Irvine, CA 92697, USA.
12. Differing phenotypes between intraepithelial and stromal lymphocytes in early-stage tongue cancer. Year Published: 2007
Department of Oral and Maxillofacial Surgery, Hamamatsu University School of Medicine, Hamamatsu, Japan. Katou@hama-med.ac.jp
13. Decreased expression of reelin receptor VLDLR in peripheral lymphocytes of drug-naive schizophrenic patients. Year Published: 2007
Department of Psychiatry and Neurology, Hamamatsu University School of Medicine, Hamamatsu, Japan.
14. Fabp7 maps to a quantitative trait locus for a schizophrenia endophenotype. Year Published: 2007
Laboratory for Molecular Psychiatry, RIKEN Brain Science Institute, Saitama, Japan.
15. Fabp7 maps to a quantitative trait locus for a schizophrenia endophenotype. Year Published: 2007
Laboratory for Molecular Psychiatry, RIKEN Brain Science Institute, Saitama, Japan.
16. D-Serine and a glycine transporter inhibitor improve MK-801-induced cognitive deficits in a novel object recognition test in rats. Year Published: 2007
Discovery Pharmacology, Molecular Function and Pharmacology Laboratories, Taisho Pharmaceutical Co. Ltd., 1-403 Yoshino-cho, Kita-ku, Saitama 331-9530, Japan.
17. Decreased serum levels of platelet-endothelial adhesion molecule (PECAM-1) in subjects with high-functioning autism: a negative correlation with head circumference at birth. Year Published: 2007
Department of Psychiatry and Neurology, Hamamatsu University School of Medicine, Hamamatsu, Shizuoka, Japan. hashimoto@faculty.chiba-u.jp
18. D-Serine and a glycine transporter inhibitor improve MK-801-induced cognitive deficits in a novel object recognition test in rats. Year Published: 2007
Discovery Pharmacology, Molecular Function and Pharmacology Laboratories, Taisho Pharmaceutical Co. Ltd., 1-403 Yoshino-cho, Kita-ku, Saitama 331-9530, Japan.
19. Phencyclidine-Induced Cognitive Deficits in Mice Are Improved by Subsequent Subchronic Administration of the Novel Selective alpha7 Nicotinic Receptor Agonist SSR180711. Year Published: 2007
Division of Clinical Neuroscience, Chiba University Center for Forensic Mental Health, Chiba.
20. Intraventricular meningioma with anaplastic transformation and metastasis via the cerebrospinal fluid. Year Published: 2007
Department of Pathology, Osaka Red Cross Hospital, Osaka, Japan. masa-s@sings.jp
21. Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of the novel selective alpha7 nicotinic receptor agonist SSR180711. Year Published: 2007
Division of Clinical Neuroscience, Chiba University Center for Forensic Mental Health, Chiba, Japan. hashimoto@faculty.chiba-u.jp
22. Differing phenotypes between intraepithelial and stromal lymphocytes in early-stage tongue cancer. Year Published: 2007
Department of Oral and Maxillofacial Surgery, Hamamatsu University School of Medicine, Hamamatsu, Japan. Katou@hama-med.ac.jp
23. Deficits in auditory P50 inhibition in obsessive-compulsive disorder. Year Published: 2008
Department of Psychiatry, Chiba University Graduate School of Medicine, Chiba, Japan.
24. Increased levels of glutamate in brains from patients with mood disorders. Year Published: 2007
Division of Clinical Neuroscience, Chiba University Center for Forensic Mental Health, Inohana, Chiba, Japan. hashimoto@faculty.chiba-u.jp
25. Glycine transporter inhibitors as therapeutic agents for schizophrenia. Year Published: 2008
Division of Clinical Neuroscience, Chiba University Center for Forensic Mental Health, Chiba 260-8670, Japan. hashimoto@faculty.chiba-u.jp.
26. Glycine transporter inhibitors as therapeutic agents for schizophrenia. Year Published: 2008
Division of Clinical Neuroscience, Chiba University Center for Forensic Mental Health, Chiba 260-8670, Japan. hashimoto@faculty.chiba-u.jp
27. Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of the antibiotic drug minocycline. Year Published: 2008
Division of Clinical Neuroscience, Chiba University Center for Forensic Mental Health, 1-8-1 Inohana, Chiba 260-8670, Japan.
28. D-Serine and a glycine transporter inhibitor improve MK-801-induced cognitive deficits in a novel object recognition test in rats. Year Published: 2007
Discovery Pharmacology, Molecular Function and Pharmacology Laboratories, Taisho Pharmaceutical Co. Ltd., 1-403 Yoshino-cho, Kita-ku, Saitama 331-9530, Japan.
29. Decreased expression of reelin receptor VLDLR in peripheral lymphocytes of drug-naive schizophrenic patients. Year Published: 2007
Department of Psychiatry and Neurology, Hamamatsu University School of Medicine, Hamamatsu, Japan.
30. Genetic examination of the PLXNA2 gene in Japanese and Chinese people with schizophrenia. Year Published: 2008
Laboratory for Molecular Psychiatry, RIKEN Brain Science Institute, Wako, Saitama 351-0198, Japan; Department of Paediatrics, Tokyo Medical University, Tokyo 160-0023, Japan.
31. Glycine transporter inhibitors as therapeutic agents for schizophrenia. Year Published: 2008
Division of Clinical Neuroscience, Chiba University Center for Forensic Mental Health, Chiba 260-8670, Japan. hashimoto@faculty.chiba-u.jp
32. Decreased expression of reelin receptor VLDLR in peripheral lymphocytes of drug-naive schizophrenic patients. Year Published: 2007
Department of Psychiatry and Neurology, Hamamatsu University School of Medicine, Hamamatsu, Japan.
33. Genetic examination of the PLXNA2 gene in Japanese and Chinese people with schizophrenia. Year Published: 2008
Laboratory for Molecular Psychiatry, RIKEN Brain Science Institute, Wako, Saitama 351-0198, Japan.
34. Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of the novel selective alpha7 nicotinic receptor agonist SSR180711. Year Published: 2007
Division of Clinical Neuroscience, Chiba University Center for Forensic Mental Health, Chiba, Japan. hashimoto@faculty.chiba-u.jp